Toward imaging of alpha-synuclein with PET
2023-03-03 07:20:58KejalKantarcietal
四川生理科學雜志 2023年9期
Kejal Kantarci , et al
Development of radiopharmaceuticals for in vivo positron emission tomography imaging of alpha-synuclein aggregates has the potential to revolutionize Lewy body disease diagnosis and treatment. Reporting in this issue of Cell, Xiang et al. developed a high-affinity positron emission tomography tracer for alpha-synuclein.
